Not provided
Not provided
Not provided
Not provided
Not provided
Not able to secure funding
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to compare clinical and patient centered outcomes of biosynthetic poly-4-hydroybutyrate meshes versus current care (synthetic polypropylene mesh or suture) for complex ventral hernia repair. The primary outcome for this study will be patients who are major complication free at 2 years postoperative. This will be a composite of hernia recurrence, reoperation, chronic wound complication, or death. Secondary outcomes include: surgical site occurences such as surgical site infection, seroma, hematoma and skin dehiscence within 90 days postoperative, emergency room visits withing 90 days postoperative, days in hospital up to 90 days postoperative, abdominal pain, and change in patient centered outcomes measured through the modified activities assessment scale (mAAS).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Phasix Mesh | Active Comparator | Phasix mesh will be used in the repair of the hernia |
|
| Current Care | Active Comparator | The hernia will be repaired with either synthetic mesh or suture repair, as determined by the operating surgeon. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Repair of ventral hernia using biologic mesh | Procedure | Ventral hernia will be repaired using biologic mesh |
|
| Measure | Description | Time Frame |
|---|---|---|
| Major complication free | A composite of hernia recurrence, reoperation, chronic wound complication, or death | 2 years post-operative |
| Measure | Description | Time Frame |
|---|---|---|
| Surgical site occurrences | Surgical site infection, seroma, hematoma, and skin dehiscence | 90 days post-operative |
| Clavien-Dindo complication grade | Clavien-Dindo complication grade |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Julie Holihan, MD | UTHealth | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Lyndon B. Johnson General Hospital | Houston | Texas | 77026 | United States | ||
| Memorial Hermann Hospital-Texas Medical Center |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006555 | Hernia, Ventral |
| ID | Term |
|---|---|
| D046449 | Hernia, Abdominal |
| D006547 | Hernia |
| D020763 | Pathological Conditions, Anatomical |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Repair of ventral hernia using suture repair or synthetic mesh | Procedure | Ventral hernia will be repaired using the current treatment methods |
|
| 90 days post-operative |
| Hospital duration | Days in hospital composed of post-operative length of stay and readmissions | 90 days post-operative |
| Emergency room visits | Number of times ER was visited | 90 days post-operative |
| Cost Analysis | Analysis of costs as performed from the healthcare perspective | 2 years |
| Post-operative abdominal pain | Measured by the visual analogue scale (VAS) | Day of consent and post-operatively at 1 month, 1 year and 2 years |
| Patient centered outcomes | Abdominal wall health status (AW-HS) measured through the modified activities assessment scale (mAAS) | Day of consent and post-operatively at 1 month, 1 year and 2 years |
| Houston |
| Texas |
| 77030 |
| United States |